DelMar Pharmaceuticals (DMPI) Presents At MicroCap Rodeo Investor Conference - Slideshow

Breakthrough Cancer Therapeutics VAL-083: Validated DNA-targeting Agent for Multiple Drug Resistant Solid Tumor Indications October 2019 NASDAQ: DMPI Forward Looking Statements Any statements contained in this presentation that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein or made in the course of the presentation are based on current expectations, but ...